SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001358403-21-000001
Filing Date
2021-01-11
Accepted
2021-01-08 18:14:10
Documents
14
Period of Report
2021-01-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K blcm-20210105.htm   iXBRL 8-K 35757
  Complete submission text file 0001358403-21-000001.txt   209189

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20210105.xsd EX-101.SCH 2423
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20210105_cal.xml EX-101.CAL 710
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20210105_def.xml EX-101.DEF 15011
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20210105_lab.xml EX-101.LAB 28964
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20210105_pre.xml EX-101.PRE 15608
7 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20210105_htm.xml XML 13444
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 21518659
SIC: 2834 Pharmaceutical Preparations